Multi-Biomarker Profiling and Recurrent Hospitalizations in Heart Failure

Area of Science:

• Cardiology
• Biomarker Research
• Clinical Prediction Models

Background:

• Heart failure (HF) patients face high rehospitalization rates despite current treatments.
• Accurate risk prediction for recurrent hospitalizations in HF remains a significant clinical challenge.

Purpose of the Study:

• To evaluate the effectiveness of a multi-biomarker panel (NT-proBNP, hs-TnT, ST2) for long-term prediction of recurrent hospitalizations in HF patients.
• To compare the predictive value of this panel against clinical assessment alone and combinations of fewer biomarkers.

Main Methods:

• Measured NT-proBNP, high-sensitivity cardiac troponin T (hs-TnT), and ST2 levels in 891 ambulatory HF patients.
• Utilized multivariable negative binomial regression to assess the association between the multi-biomarker panel and recurrent hospitalizations (all-cause, CV-, HF-related).
• Employed McFadden pseudo-R^2 and goodness-of-fit measures to evaluate model performance.

Main Results:

• Over a mean follow-up of 4.2 years, 55.9% of patients experienced all-cause hospitalizations.
• Patients with biomarker levels above defined cut-points (hs-TnT > 14 ng/L, NT-proBNP > 1000 ng/L, ST2 > 35 ng/mL) had significantly higher rates of all-cause, CV-, and HF-related hospitalizations (P < 0.001).
• Incorporating the multi-biomarker panel into clinical models significantly improved predictive accuracy.

Conclusions:

• A multi-biomarker approach using NT-proBNP, hs-TnT, and ST2 provides superior risk stratification for recurrent hospitalizations in HF patients.
• This comprehensive panel identifies at-risk individuals more effectively than using one or two biomarkers.
• Further research into novel biophysiological predictors could enable targeted interventions for specific HF patient profiles.